Feng, Guang <br/><br/>
Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.  [electronic resource] 

 -  International immunopharmacology  Jun 2015 
 - 392-400 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2015.04.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Lung Injury--chemically induced<br/>Animals<br/>Anti-Inflammatory Agents--administration & dosage<br/>Cell Line<br/>Cell Movement--drug effects<br/>Cytokines--metabolism<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Isoflavones--administration & dosage<br/>Lipopolysaccharides--immunology<br/>Lung--drug effects<br/>Macrophages--drug effects<br/>Male<br/>NF-kappa B--genetics<br/>Neutrophils--drug effects<br/>Peroxidase--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Toll-Like Receptor 4--metabolism